title: A mesothelioma that is sensitive to locally applied IL-2.
authors.forename: Z
authors.initials: Z
authors.lastname: Krastev
authors.forename: V
authors.initials: V
authors.lastname: Koltchakov
authors.forename: N
authors.initials: N
authors.lastname: Vladov
authors.forename: D
authors.initials: D
authors.lastname: Popov
authors.forename: A
authors.initials: A
authors.lastname: Milev
authors.forename: J W
authors.initials: JW
authors.lastname: Koten
authors.forename: W
authors.initials: W
authors.lastname: Den Otter
mesh_terms: D006801:Humans; D007263:Infusions, Parenteral; D007376:Interleukin-2 / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D007376:Interleukin-2